Kaolin-induced chronic hydrocephalus accelerates amyloid deposition and vascular disease in transgenic rats expressing high levels of human APP

BackgroundNormal pressure hydrocephalus (NPH) is most common in the elderly and has a high co-morbidity with Alzheimer’s disease (AD) and cerebrovascular disease (CVD). To understand the relationship between NPH, AD and CVD, we investigated how chronic hydrocephalus impacts brain amyloid-beta peptide (Aβ) accumulation and vascular pathology in an AD transgenic rodent model. Previously we showed that the altered CSF physiology produced by kaolin-hydrocephalus in older wild-type Sprague–Dawley rats increased Aβ and hyperphosphorylated Tau (Silverberg et. al. Brain Res. 2010, 1317:286–296). We postulated that hydrocephalus would similarly affect an AD rat model.MethodsThirty-five transgenic rats (tgAPP21) that express high levels of human APP and naturally overproduce Aβ40 were used. Six- (n = 7) and twelve-month-old (n = 9) rats had hydrocephalus induced by cisternal kaolin injection. We analyzed Aβ burden (Aβ40, Aβ42 and oligomeric Aβ) and vascular integrity (Masson trichrome and Verhoeff-Van Gieson) by immunohistochemistry and chemical staining at 10 weeks (n = 8) and 6 months (n = 5) post hydrocephalus induction. We also analyzed whether the vascular pathology seen in tgAPP21 rats, which develop amyloid angiopathy, was accelerated by hydrocephalus. Age-matched naïve and sham-operated tgAPP21 rats served as controls (n = 19).ResultsIn hydrocephalic tgAPP21 rats, compared to naïve and sham-operated controls, there was increased Aβ 40 and oligomeric Aβ in hippocampal and cortical neurons at 10 weeks and 6 months post-hydrocephalus induction. No dense-core amyloid plaques were seen, but diffuse Aβ immunoreactivity was evident in neurons. Vascular pathology was accelerated by the induction of hydrocephalus compared to controls. In the six-month-old rats, subtle degenerative changes were noted in vessel walls at 10 weeks post-kaolin, whereas at six months post-kaolin and in the 12-month-old hydrocephalic rats more pronounced amyloid angiopathic changes were seen, with frequent large areas of infarction noted.ConclusionsKaolin-hydrocephalus can accelerate intraneuronal Aβ40 accumulation and vascular pathology in tgAPP21 rats. In addition, disrupted CSF production and reduced CSF turnover results in impaired Aβ clearance and accelerated vascular pathology in chronic hydrocephalus. The high co-morbidity seen in NPH, AD and CVD is likely not to be an age-related coincidence, but rather a convergence of pathologies related to diminished CSF clearance.

[1]  G. Silverberg Normal pressure hydrocephalus (NPH): ischaemia, CSF stagnation or both. , 2004, Brain : a journal of neurology.

[2]  Lee G Luna,et al.  Manual of histologic staining methods of the Armed forces institute of pathology , 1968 .

[3]  P. Conn Neuroscience in Medicine , 2003, Humana Press.

[4]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[5]  Amir Samii,et al.  Brain amyloid accumulates in aged rats with kaolin-induced hydrocephalus , 2006, Neuroreport.

[6]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[7]  G. Hochwald,et al.  Effect of spinal fluid pressure on cerebrospinal fluid formation. , 1971, Experimental neurology.

[8]  H. D. Vries fluids and barriers of the CNS , 2010 .

[9]  L. Hersh,et al.  Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.

[10]  B. Zlokovic Clearing amyloid through the blood–brain barrier , 2004, Journal of neurochemistry.

[11]  T. Saido,et al.  Metabolic regulation of brain Abeta by neprilysin. , 2001, Science.

[12]  M. Samii,et al.  Sinusoidal Intrathecal Infusion for Assessment of CSF Dynamics in Kaolin-Induced Hydrocephalus , 1998, Acta Neurochirurgica.

[13]  L Symon,et al.  Pressure waves in so-called low-pressure hydrocephalus. , 1972, Lancet.

[14]  W. Oldendorf,et al.  Brain extracellular space and the sink action of cerebrospinal fluid. , 1967, Transactions of the American Neurological Association.

[15]  Miles C. Miller,et al.  Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent , 2011, Fluids and Barriers of the CNS.

[16]  J. Lah,et al.  Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats , 2012, Journal of neurochemistry.

[17]  G. Silverberg,et al.  Alzheimer's disease, normal‐pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis , 2003, The Lancet Neurology.

[18]  R. D. Adams,et al.  The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. , 1965, Journal of the neurological sciences.

[19]  Steven D Chang,et al.  Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalus. , 2002, Journal of neurosurgery.

[20]  T. Saido,et al.  Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.

[21]  R. Carare,et al.  SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease , 2007 .

[22]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[23]  D. Holtzman,et al.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.

[24]  T. Saido,et al.  Metabolic Regulation of Brain Aβ by Neprilysin , 2001, Science.

[25]  G. Heit,et al.  The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer’s type , 2001, Neurology.

[26]  A. Kluger,et al.  Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  R O Weller,et al.  Review: Cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy , 2013, Neuropathology and applied neurobiology.

[28]  D. Selkoe,et al.  Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.

[29]  Miles C. Miller,et al.  Amyloid Deposition and Influx Transporter Expression at the Blood-Brain Barrier Increase in Normal Aging , 2010, Journal of neuropathology and experimental neurology.

[30]  W. Seeger,et al.  The relation of intracranial pressure B-waves to different sleep stages in patients with suspected normal pressure hydrocephalus , 2005, Acta Neurochirurgica.

[31]  O. R. Blaumanis,et al.  Rapid solute transport throughout the brain via paravascular fluid pathways. , 1990, Advances in neurology.

[32]  Miles C. Miller,et al.  Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging , 2010, Journal of neuropathology and experimental neurology.

[33]  Ann Marie Schmidt,et al.  RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain , 2003, Nature Medicine.

[34]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[35]  R. Deane,et al.  Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.

[36]  C. Hug Transport in the Central Nervous System , 1971 .

[37]  T. Saido,et al.  Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' , 2000, Nature Medicine.

[38]  E. Heyderman Histotechnology. A self‐instructional text , 1992 .

[39]  H. Mori,et al.  Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form , 2003, Neuroscience Letters.

[40]  D. Holtzman,et al.  Clearance of amyloid beta-peptide from brain: transport or metabolism? , 2000, Nature medicine.

[41]  G. Bateman,et al.  The Pathophysiology of Idiopathic Normal Pressure Hydrocephalus: Cerebral Ischemia or Altered Venous Hemodynamics? , 2008, American Journal of Neuroradiology.

[42]  Amir Samii,et al.  Cerebral Hypoperfusion and Delayed Hippocampal Response After Induction of Adult Kaolin Hydrocephalus , 2003, Stroke.

[43]  L. Symon,et al.  Use of long-term intracranial pressure measurement to assess hydrocephalic patients prior to shunt surgery. , 1975, Journal of neurosurgery.

[44]  M. Camins,et al.  The rat in experimental obstructive hydrocephalus. , 1981, Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood.

[45]  P. Hellström,et al.  The European iNPH Multicentre Study on the predictive values of resistance to CSF outflow and the CSF Tap Test in patients with idiopathic normal pressure hydrocephalus , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  Miles C. Miller,et al.  Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months , 2012, Fluids and Barriers of the CNS.

[47]  The Warren Alpert Medical School of Brown University. , 2010, Academic medicine : journal of the Association of American Medical Colleges.

[48]  W. Oldendorf,et al.  Brain extracellular space and the sink action of cerebrospinal fluid. Measurement of rabbit brain extracellular space using sucrose labeled with carbon 14. , 1967, Archives of neurology.

[49]  W. Halliday,et al.  Neuropathological Changes in Chronic Adult Hydrocephalus: Cortical Biopsies and Autopsy Findings , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[50]  O. Sletvold,et al.  Alterations in brain metabolism, CNS morphology and CSF dynamics in adult rats with kaolin-induced hydrocephalus , 2002, Brain Research.

[51]  A. Levey,et al.  Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically , 2008, BMC Neuroscience.

[52]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[53]  Miles C. Miller,et al.  Amyloid and Tau accumulate in the brains of aged hydrocephalic rats , 2010, Brain Research.

[54]  S. Ekholm,et al.  White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination , 2002, Acta neurologica Scandinavica.

[55]  S. Savolainen,et al.  Prevalence of Alzheimer's Disease in Patients Investigated for Presumed Normal Pressure Hydrocephalus: A Clinical and Neuropathological Study , 1999, Acta Neurochirurgica.

[56]  W. Oldendorf,et al.  Symposium on membrane transport. Transport in the central nervous system. , 1967, Proceedings of the Royal Society of Medicine.

[57]  John Hardy,et al.  A Hundred Years of Alzheimer's Disease Research , 2006, Neuron.